Counterintuitive effect of antiviral therapy on influenza A-SARS-CoV-2 coinfection due to viral interference

The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied virus-virus and host-virus interactions during influenza A virus (IAV) -SARS-CoV-2 coinfection using differentiated cultures of the human airway...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:bioRxiv
Hlavní autoři: Cheemarla, Nagarjuna R, Mihaylova, Valia T, Watkins, Timothy A, Foxman, Ellen F
Médium: Journal Article Paper
Jazyk:angličtina
Vydáno: United States Cold Spring Harbor Laboratory Press 08.02.2023
Cold Spring Harbor Laboratory
Vydání:1.1
Témata:
Antiviral agents
Epithelium
Immunology
Influenza A
Oseltamivir
Replication
Severe acute respiratory syndrome coronavirus 2
Viruses
COVID-19
SARS-CoV-2
Tamiflu
respiratory virus
viral interference
influenza virus
oseltamivir
coinfection
interferon stimulated genes
interferon response
ISSN:2692-8205, 2692-8205
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied virus-virus and host-virus interactions during influenza A virus (IAV) -SARS-CoV-2 coinfection using differentiated cultures of the human airway epithelium. Coexposure to IAV enhanced the tissue antiviral response during SARS-CoV-2 infection and suppressed SARS-CoV-2 replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the antiviral response and paradoxically restored SARS-CoV-2 replication. These results highlight the importance of diagnosing coinfections and compel further study of how coinfections impact the outcome of antiviral therapy.
AbstractList The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied virus-virus and host-virus interactions during influenza A virus (IAV) -SARS-CoV-2 coinfection using differentiated cultures of the human airway epithelium. Coexposure to IAV enhanced the tissue antiviral response during SARS-CoV-2 infection and suppressed SARS-CoV-2 replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the antiviral response and paradoxically restored SARS-CoV-2 replication. These results highlight the importance of diagnosing coinfections and compel further study of how coinfections impact the outcome of antiviral therapy.
The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied virus-virus and host-virus interactions during influenza A virus (IAV) -SARS-CoV-2 coinfection using differentiated cultures of the human airway epithelium. Coexposure to IAV enhanced the tissue antiviral response during SARS-CoV-2 infection and suppressed SARS-CoV-2 replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the antiviral response and paradoxically restored SARS-CoV-2 replication. These results highlight the importance of diagnosing coinfections and compel further study of how coinfections impact the outcome of antiviral therapy.The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied virus-virus and host-virus interactions during influenza A virus (IAV) -SARS-CoV-2 coinfection using differentiated cultures of the human airway epithelium. Coexposure to IAV enhanced the tissue antiviral response during SARS-CoV-2 infection and suppressed SARS-CoV-2 replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the antiviral response and paradoxically restored SARS-CoV-2 replication. These results highlight the importance of diagnosing coinfections and compel further study of how coinfections impact the outcome of antiviral therapy.
The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied virus-virus and host-virus interactions during influenza A virus (IAV) -SARS-CoV-2 coinfection using differentiated cultures of the human airway epithelium. Coexposure to IAV enhanced the tissue antiviral response during SARS-CoV-2 infection and suppressed SARS-CoV-2 replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the antiviral response and paradoxically restored SARS-CoV-2 replication. These results highlight the importance of diagnosing coinfections and compel further study of how coinfections impact the outcome of antiviral therapy.Competing Interest StatementThe authors have declared no competing interest.
Author Cheemarla, Nagarjuna R
Mihaylova, Valia T
Foxman, Ellen F
Watkins, Timothy A
Author_xml – sequence: 1
  givenname: Nagarjuna R
  surname: Cheemarla
  fullname: Cheemarla, Nagarjuna R
  organization: Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520
– sequence: 2
  givenname: Valia T
  surname: Mihaylova
  fullname: Mihaylova, Valia T
  organization: Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520
– sequence: 3
  givenname: Timothy A
  surname: Watkins
  fullname: Watkins, Timothy A
  organization: Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520
– sequence: 4
  givenname: Ellen F
  surname: Foxman
  fullname: Foxman, Ellen F
  organization: Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06520
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36798412$$D View this record in MEDLINE/PubMed
BookMark eNpdkFtLxDAQhYOsuOvlB_giAV986ZpM2iZ9XBZvsCC46mtJ0ylGusmatqL-eiO7XvBphpnvnGHOPhk575CQY86mnDN-DgzElMGUyWkGUkjYIRPIC0gUsGz0px-To657ZoxBkXMh0z0yFrksVMphQtq5H1yPwbp-sL19RYpNg6anvqHaxYENuqX9Ewa9fqfeUeuadkD3oeksWc7ulsncPyZAjY-LqLMRqQekvacbqf1ybzCgM3hIdhvddni0rQfk4fLifn6dLG6vbuazRVIBzyCptUCVGpVLxou6UtrkTQV1hnWmRZqKlBtdKZHnqEVlWK65kSZjsqgAaqxRHJCzjW9lfXizr-U62JUO7-VXZiWDkslyk9kvug7-ZcCuL1e2M9i22qEfuhKkEqkqJFMRPf2HPvshuPhIpGQqshgwj9TJlhqqFdY_p78jF5_6d4Qx
ContentType Journal Article
Paper
Copyright 2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023, Posted by Cold Spring Harbor Laboratory
Copyright_xml – notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023, Posted by Cold Spring Harbor Laboratory
DBID NPM
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
FX.
DOI 10.1101/2023.02.07.527372
DatabaseName PubMed
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
bioRxiv
DatabaseTitle PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2692-8205
Edition 1.1
ExternalDocumentID 2023.02.07.527372v1
36798412
Genre Preprint
Working Paper/Pre-Print
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: T32 AI055403
GroupedDBID NPM
8FE
8FH
ABUWG
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
GNUQQ
HCIFZ
LK8
M7P
NQS
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PROAC
RHI
7X8
PUEGO
FX.
ID FETCH-LOGICAL-b2152-da3e84c867019db8ac6fb2d5ed5a344341cab8366ea3bc06a1c7c5079b22dede3
IEDL.DBID M7P
ISSN 2692-8205
IngestDate Tue Jan 07 18:57:58 EST 2025
Thu Sep 04 20:54:46 EDT 2025
Fri Jul 25 09:20:48 EDT 2025
Wed Feb 19 02:09:45 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Keywords COVID-19
SARS-CoV-2
Tamiflu
respiratory virus
viral interference
influenza virus
oseltamivir
coinfection
interferon stimulated genes
interferon response
Language English
License This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b2152-da3e84c867019db8ac6fb2d5ed5a344341cab8366ea3bc06a1c7c5079b22dede3
Notes SourceType-Working Papers-1
ObjectType-Working Paper/Pre-Print-1
content type line 50
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
Competing Interest Statement: The authors have declared no competing interest.
ORCID 0000-0001-9767-9942
OpenAccessLink https://www.proquest.com/docview/2774350291?pq-origsite=%requestingapplication%
PMID 36798412
PQID 2774350291
PQPubID 2050091
PageCount 14
ParticipantIDs biorxiv_primary_2023_02_07_527372
proquest_miscellaneous_2783489708
proquest_journals_2774350291
pubmed_primary_36798412
PublicationCentury 2000
PublicationDate 2023-Feb-08
20230208
PublicationDateYYYYMMDD 2023-02-08
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-Feb-08
  day: 08
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Cold Spring Harbor
PublicationTitle bioRxiv
PublicationTitleAlternate bioRxiv
PublicationYear 2023
Publisher Cold Spring Harbor Laboratory Press
Cold Spring Harbor Laboratory
Publisher_xml – name: Cold Spring Harbor Laboratory Press
– name: Cold Spring Harbor Laboratory
References Wu, Mihaylova, Landry, Foxman (2023.02.07.527372v1.5) 2020; 1
Dee, Schultz, Haney, Bissett, Magill, Murcia (2023.02.07.527372v1.4) 2022
Schneider, Chevillotte, Rice (2023.02.07.527372v1.10) 2014; 32
Kim, Nguyen, Casel (2023.02.07.527372v1.13) 2022; 96
2023.02.07.527372v1.11
Oishi, Horiuchi, Minkoff, tenOever (2023.02.07.527372v1.3) 2022; 96
Cox, Gonzalez, Ijezie (2023.02.07.527372v1.8) 2022; 13
Swets, Russell, Harrison (2023.02.07.527372v1.12) 2022; 399
Essaidi-Laziosi, Alvarez, Puhach (2023.02.07.527372v1.2) 2021
Halfmann, Nakajima, Sato (2023.02.07.527372v1.1) 2022; 225
Park, Iwasaki (2023.02.07.527372v1.9) 2020; 27
Cheemarla, Watkins, Mihaylova (2023.02.07.527372v1.6) 2021; 218
Gonzalez, Ijezie, Balemba, Miura (2023.02.07.527372v1.7) 2018; 92
Huang, Skarlupka, Jang (2023.02.07.527372v1.14) 2022; 96
Dee, Goldfarb, Haney (2023.02.07.527372v1.15) 2021; 224
References_xml – volume: 92
  year: 2018
  ident: 2023.02.07.527372v1.7
  article-title: Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model
  publication-title: J Virol
– volume: 225
  start-page: 282
  year: 2022
  end-page: 6
  ident: 2023.02.07.527372v1.1
  article-title: SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
  publication-title: The Journal of infectious diseases
– year: 2022
  ident: 2023.02.07.527372v1.4
  article-title: Influenza A and respiratory syncytial virus trigger a cellular response that blocks severe acute respiratory syndrome virus 2 infection in the respiratory tract
  publication-title: The Journal of infectious diseases
– volume: 1
  start-page: e254
  year: 2020
  end-page: e62
  ident: 2023.02.07.527372v1.5
  article-title: Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study
  publication-title: Lancet Microbe
– volume: 13
  start-page: 886611
  year: 2022
  ident: 2023.02.07.527372v1.8
  article-title: Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection
  publication-title: Front Immunol
– ident: 2023.02.07.527372v1.11
  publication-title: World Health Organization: FluNet
– volume: 399
  start-page: 1463
  year: 2022
  end-page: 4
  ident: 2023.02.07.527372v1.12
  article-title: SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
  publication-title: Lancet
– volume: 96
  start-page: e0187321
  year: 2022
  ident: 2023.02.07.527372v1.13
  article-title: Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4(+) T Cell Responses
  publication-title: J Virol
– volume: 96
  start-page: e0179121
  year: 2022
  ident: 2023.02.07.527372v1.14
  article-title: SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
  publication-title: J Virol
– volume: 96
  start-page: e0076522
  year: 2022
  ident: 2023.02.07.527372v1.3
  article-title: The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection
  publication-title: J Virol
– volume: 32
  start-page: 513
  year: 2014
  end-page: 45
  ident: 2023.02.07.527372v1.10
  article-title: Interferon-stimulated genes: a complex web of host defenses
  publication-title: Annual review of immunology
– volume: 27
  start-page: 870
  year: 2020
  end-page: 8
  ident: 2023.02.07.527372v1.9
  article-title: Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
  publication-title: Cell Host Microbe
– volume: 224
  start-page: 31
  year: 2021
  end-page: 8
  ident: 2023.02.07.527372v1.15
  article-title: Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology
  publication-title: The Journal of infectious diseases
– volume: 218
  year: 2021
  ident: 2023.02.07.527372v1.6
  article-title: Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics
  publication-title: J Exp Med
– start-page: 1
  year: 2021
  end-page: 26
  ident: 2023.02.07.527372v1.2
  article-title: Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract
  publication-title: Emerg Microbes Infect
SSID ssj0002961374
Score 1.821838
SecondaryResourceType preprint
Snippet The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied...
SourceID biorxiv
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
SubjectTerms Antiviral agents
Epithelium
Immunology
Influenza A
Oseltamivir
Replication
Severe acute respiratory syndrome coronavirus 2
Viruses
Title Counterintuitive effect of antiviral therapy on influenza A-SARS-CoV-2 coinfection due to viral interference
URI https://www.ncbi.nlm.nih.gov/pubmed/36798412
https://www.proquest.com/docview/2774350291
https://www.proquest.com/docview/2783489708
https://www.biorxiv.org/content/10.1101/2023.02.07.527372
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2692-8205
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002961374
  issn: 2692-8205
  databaseCode: M7P
  dateStart: 20131107
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2692-8205
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002961374
  issn: 2692-8205
  databaseCode: BENPR
  dateStart: 20131107
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2692-8205
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002961374
  issn: 2692-8205
  databaseCode: PIMPY
  dateStart: 20131107
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZol0qceJeFsjISV4PXTmL7hErVCg5dRS2g5RT5KUWq4iW7W1F-PZ44u5zgwiWHPBxrxuMZez5_g9BbFTzlwSsSguWkEEIRrXwgFbMFdcoZwXKxCbFYyOVS1eOG23qEVe7mxGGidtHCHvl7luIUXlKm5h9WPwhUjYLs6lhC4wBNgCWBDdC9er_HwlRyVgMRM6tUMnxGyzGxmQYiLPv5wNcp3gELGXAEH5k29j_b27-Hm4PbuXj4vx1-hCa1Xvn-MbrnuyfoKBeevHuKbuAoOrA0J48zgIdwxnXgGHASdQvI3xucz2bd4djhNtcy-aXxKbk-vbomZ_EbYdjGHZirw27r8Sbi_CmwUPTjUcJn6OvF-ZezT2Ssu0AMCJE4zb0srKyAqt0ZqW0VDHOld6XmRZH8ntVG8qrymhtLKz23wqa4UhnGnHeeP0eHXez8C4S59SqUypXc-MJUQWlurafUaF7xFLtM0ZtR5M0qs2s0oJaGsoaKJqtlik52Am5GA1s3f6Sbmtg_TqYB-Q7d-biFdyQvpBJUTtFxVuL-LxyyT8Wcvfx346_QA-jPANOWJ-hw02_9a3Tf3m7adT9DB2IpZ2jy8XxRX82GsZeui_oy3as_X9bffwOpIuFt
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLRWceMNCC0aCo8Fr5-VDhaqWqqu2qxUtqJyCX5EiVcmS3S0sP6q_EU-cLCe49cA5iZN4vownnpnvA3gjC8dE4SQtCiNolKaSKukKmnATMSutTnkQm0gnk-ziQk434LrvhcGyyt4nto7a1gb3yN9zH6eImHE5-jD7TlE1CrOrvYRGgMWxW_3wv2zz3fGBt-9bzg8_nu8f0U5VgGrUcKVWCZdFJkuQiNzqTJmk0NzGzsZKRJH36kbpTCSJU0IblqiRSY2PmqTm3DrrhB_3FmxGCPYBbE7Hp9Ov610dLv3y2FI_80R6V8NZ3KVSPfRxo0G0DKHpO-Q9Q1biLV3Wzc_y6u8BbrvQHd7736bovp8aNXPNA9hw1UPYCtKaq0dwic32yEPt19S2PIqEyhVSF8SDqcTa5ksSus9WpK5IGdRafimyR8_2Pp3R_foL5cTUfblaRezSkUVNwqXIs9F0zZKP4fONvOATGFR15Z4BEcbJIpY2FtpFOimkEsY4xrQSifDR2RBedybOZ4E_JEcY5IznLM0DDIaw3Rs071zIPP9jTT_E-rD_-DGjoypXL_GcTESZTFk2hKcBNOu7CMyvRSP-_N-Dv4I7R-enJ_nJeHL8Au7is7VF6dk2DBbN0u3AbXO1KOfNyw7rBL7dNHZ-AysqPCU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Counterintuitive+effect+of+antiviral+therapy+on+influenza+A-SARS-CoV-2+coinfection+due+to+viral+interference&rft.jtitle=bioRxiv&rft.au=Cheemarla%2C+Nagarjuna+R&rft.au=Mihaylova%2C+Valia+T&rft.au=Watkins%2C+Timothy+A&rft.au=Foxman%2C+Ellen+F&rft.date=2023-02-08&rft.issn=2692-8205&rft.eissn=2692-8205&rft_id=info:doi/10.1101%2F2023.02.07.527372&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2692-8205&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2692-8205&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2692-8205&client=summon